Literature DB >> 21830164

Delayed exercise-induced functional and neurochemical partial restoration following MPTP.

Trevor Archer1, Anders Fredriksson.   

Abstract

In two experiments, MPTP was administered to C57/BL6 mice according to a single-dose weekly regime (MPTP: 1 × 30 mg/kg on the fifth day of the week, Friday, over 4 weeks) with vehicle group (Vehicle: 1 × 5 ml/kg) treated concurrently. Exercise schedules (delayed) were introduced either at the beginning of the week after the second MPTP injection (MPTP + Exercise(2) group), or at the beginning of the week after the fourth MPTP injection (MPTP + Exercise(4) group). Wheel-running was provided on the first 4 days of each week (Monday-Thursday) more than 30-min periods. In Experiment I, wheel-running exercise was introduced either after 2 or 4 weeks after MPTP/Vehicle. MPTP and Vehicle groups not provided access to the running wheels were placed in single cages within the wheel-running room over 30-min concomitantly with the wheel-running groups. In Experiment II, wheel-running exercise was introduced 2 weeks after MPTP/Vehicle but a no-exercise control group with non-revolving wheel included (MPTP-Wheel). In both experiments, spontaneous motor activity tests during 60-min intervals were performed at the end (Fridays) of weeks 1, 2, 3, 4, 6, 8, and 10, where the week on which the first injection of MPTP was the first week; in the case of weeks 1-4, this was immediately before MPTP/Vehicle injections. It was observed that the introduction of the exercise schedule after the second MPTP injection, but not after the fourth injection, restored motor activity that had been markedly elevated by the end of the tenth week. Subthreshold administration of L-dopa tests was performed after the spontaneous motor activity tests 6, 8 and 10; these indicated significant effects of exercise, MPTP + Exercise(2) group, on Tests 6 and 8, but not Test 10. The physical exercise schedule in that group also showed markedly attenuated loss of dopamine (DA). Restoration of MPTP-induced motor activity deficits and DA loss was a function of the point at which exercise was introduced, in the present case after two administrations of the neurotoxin. In Experiment II, physical exercise markedly attenuated the hypokinesic effect of MPTP in the exercise condition, MPTP-exercise, but not in the non-exercise conditions, MPTP-Cage and MPTP-Wheel, for both spontaneous motor activity and L-dopa-induced activity. MPTP-induced loss of DA was also attenuated by exercise.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21830164     DOI: 10.1007/s12640-011-9261-z

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  57 in total

1.  Wheel running use in dopamine D2L receptor knockout mice.

Authors:  Héctor Vargas-Pérez; Emiliana Borrelli; José-Luis Díaz
Journal:  Neurosci Lett       Date:  2004-08-12       Impact factor: 3.046

2.  Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.

Authors:  Eleni Antzoulatos; Michael W Jakowec; Giselle M Petzinger; Ruth I Wood
Journal:  Pharmacol Biochem Behav       Date:  2010-03-27       Impact factor: 3.533

3.  MPTP-induced hypoactivity in mice: reversal by L-dopa.

Authors:  A Fredriksson; A Plaznik; E Sundström; G Jonsson; T Archer
Journal:  Pharmacol Toxicol       Date:  1990-10

4.  Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration.

Authors:  Yuen-Sum Lau; Gaurav Patki; Kaberi Das-Panja; Wei-Dong Le; S Omar Ahmad
Journal:  Eur J Neurosci       Date:  2011-03-07       Impact factor: 3.386

5.  Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF.

Authors:  Ann D Cohen; Jennifer L Tillerson; Amanda D Smith; Timothy Schallert; Michael J Zigmond
Journal:  J Neurochem       Date:  2003-04       Impact factor: 5.372

6.  Comparing exercise in Parkinson's disease--the Berlin LSVT®BIG study.

Authors:  Georg Ebersbach; Almut Ebersbach; Daniela Edler; Olaf Kaufhold; Matthias Kusch; Andreas Kupsch; Jörg Wissel
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

7.  Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration.

Authors:  Anders Fredriksson; Trevor Archer
Journal:  Behav Brain Res       Date:  2003-02-17       Impact factor: 3.332

8.  Exercise therapy for Parkinson's disease.

Authors:  S S Palmer; J A Mortimer; D D Webster; R Bistevins; G L Dickinson
Journal:  Arch Phys Med Rehabil       Date:  1986-10       Impact factor: 3.966

Review 9.  Delaying mobility disability in people with Parkinson disease using a sensorimotor agility exercise program.

Authors:  Laurie A King; Fay B Horak
Journal:  Phys Ther       Date:  2009-02-19

10.  (S)-UH-301 antagonizes (R)-8-OH-DPAT-induced cardiovascular effects in the rat.

Authors:  L Björk; S Lindgren; U Hacksell; T Lewander
Journal:  Eur J Pharmacol       Date:  1991-07-09       Impact factor: 4.432

View more
  3 in total

1.  The yeast product Milmed enhances the effect of physical exercise on motor performance and dopamine neurochemistry recovery in MPTP-lesioned mice.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurotox Res       Date:  2013-07-27       Impact factor: 3.911

2.  Running-Activated Neural Stem Cells Enhance Subventricular Neurogenesis and Improve Olfactory Behavior in p21 Knockout Mice.

Authors:  Vittoria Nicolis di Robilant; Raffaella Scardigli; Georgios Strimpakos; Felice Tirone; Silvia Middei; Chiara Scopa; Marco De Bardi; Luca Battistini; Daniele Saraulli; Stefano Farioli Vecchioli
Journal:  Mol Neurobiol       Date:  2019-05-06       Impact factor: 5.590

3.  Restoration of MPTP-induced deficits by exercise and Milmed(®) co-treatment.

Authors:  Trevor Archer; Danilo Garcia; Anders Fredriksson
Journal:  PeerJ       Date:  2014-08-26       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.